Innovision shares to list today. Here’s what GMP indicates ahead of debut – News Air Insight

Spread the love


Innovision shares are headed for listing on March 23 with grey market signals indicating a weak debut, as the GMP has slipped into negative territory ahead of listing. The Rs 319 crore IPO, which was priced at Rs 519 per share at the upper end of the band, is currently commanding a negative GMP, implying a potential listing below the issue price if the trend sustains.

The muted GMP comes despite the issue seeing an overall subscription of 3.46 times, driven largely by strong institutional and high net-worth investor participation. The QIB portion was subscribed 14.30 times, while the NII segment saw 8.60 times subscription. In contrast, retail demand remained weak at just 0.60 times, indicating limited broader investor participation.

The negative GMP reflects concerns around valuation and business profile rather than demand visibility. The IPO was a mix of fresh issue worth Rs 255 crore and an offer for sale of Rs 64 crore.

Proceeds from the fresh issue are earmarked for debt repayment, working capital requirements and general corporate purposes.

Innovision operates in manpower services, toll plaza management and skill development, with a diversified presence across 23 states and 5 union territories. However, analysts have flagged that the company operates in a highly competitive and fragmented segment, which could cap valuation upside in the near term.


At the issue price, the company is valued at a post-issue P/E of 30.89x, which is seen as relatively expensive compared to peers, especially given its modest margin profile.

While the company has demonstrated growth in both revenue and profitability over recent years, concerns around pricing and limited retail participation appear to be weighing on near-term listing expectations.That said, grey market trends are unofficial and can change closer to listing. Final listing performance will depend on broader market sentiment, institutional support and overall risk appetite.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *